Viridian Therapeutics Stock (NASDAQ:VRDN), Quotes and News Summary

Q: What sector and industry does Viridian Therapeutics (VRDN) operate in?

Viridian Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Viridian Therapeutics Stock (NASDAQ: VRDN) stock price, news, charts, stock research, profile.

Open	$14.380
Close	$13.030
Volume / Avg.	771.185K / 902.210K
Day Range	12.990 - 14.680
52 Wk Range	10.925 - 30.300
Market Cap	$817.861M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	22
Short Interest	15.43%
Days to Cover	9.36

Recent News

Here's Why Viridian Therapeutics (VRDN) Stock Is Moving

Viridian Therapeutics shares are trading lower by 5.9% Thursday morning. The company announced pricing of an underwritten public offering.

Henry Khederian

ZimVie Agrees To Sell Its Spine Business, Joins United States Steel, PGT Innovations And Other Big Stocks Moving Higher On Monday

U.S. stocks traded mostly higher, with the Nasdaq Composite gaining around 30 points on Monday.

Avi Kapoor

Western Digital, JinkoSolar, Lumentum Holdings And Other Big Stocks Moving Higher On Monday

U.S. stocks traded higher, with the Nasdaq Composite gaining more than 100 points on Monday. Here are some big stocks recording gains in today’s session.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Oct 23

Nov 23

Dec 23

Feb

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating

4.4

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Viridian Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing m...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Viridian Therapeutics (VRDN) stock?

You can purchase shares of Viridian Therapeutics (NASDAQ: VRDN) through any online brokerage.

View our list of the best stock brokerages.

Who are Viridian Therapeutics's (VRDN) competitors?

Other companies in Viridian Therapeutics’s space includes: Macrogenics (NASDAQ:MGNX), Immunome (NASDAQ:IMNM), ARS Pharmaceuticals (NASDAQ:SPRY), 89bio (NASDAQ:ETNB) and Zentalis Pharma (NASDAQ:ZNTL).

What is the target price for Viridian Therapeutics (VRDN) stock?

The latest price target for Viridian Therapeutics (NASDAQ: VRDN) was reported by B. Riley Securities on Thursday, March 21, 2024. The analyst firm set a price target for 25.00 expecting VRDN to rise to within 12 months (a possible 91.86% upside). 35 analyst firms have reported ratings in the last year.

Current Stock Price for Viridian Therapeutics (VRDN)?

The stock price for Viridian Therapeutics (NASDAQ: VRDN) is $13.03 last updated April 24, 2024 at 4:20 PM EDT.

Does Viridian Therapeutics (VRDN) pay a dividend?

There are no upcoming dividends for Viridian Therapeutics.

When is Viridian Therapeutics (NASDAQ:VRDN) reporting earnings?

Viridian Therapeutics’s Q1 earnings are confirmed for Tuesday, May 7, 2024.

Is Viridian Therapeutics (VRDN) going to split?

There is no upcoming split for Viridian Therapeutics.

What sector and industry does Viridian Therapeutics (VRDN) operate in?

Viridian Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-